HEATHER DITTO: Open Payments
NPI 1346736717 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 87 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $1,868
Food & beverage: $1,868
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 24 | $503 |
| Insmed, Inc. | 14 | $257 |
| GENZYME CORPORATION | 12 | $224 |
| Regeneron Healthcare Solutions, Inc. | 13 | $223 |
| AstraZeneca Pharmaceuticals LP | 4 | $208 |
| Verona Pharma, Inc. | 4 | $82 |
| Merck Sharp & Dohme LLC | 4 | $76 |
| Boston Scientific Corporation | 1 | $58 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Viatris Specialty LLC | 2 | $42 |
Products named: NUCALA, DUPIXENT, Arikayce, TEZSPIRE, FABRAZYME, AIRSUPRA, TRELEGY ELLIPTA, Ohtuvayre.
Industry payments across AR — which companies pay providers there.
